Clinical Trial Update: Communicating Smoking Risks Through Graphic Warning Labels [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluated the effectiveness of graphic warning labels in communicating smoking risks.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease
• Lung Cancer

Snippet

Sponsor: University of Pennsylvania | Conditions: Lung Cancer, Heart Disease | Phase 3 | Status: COMPLETED